InvestorsHub Logo
Followers 828
Posts 119591
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Wednesday, 03/29/2017 3:13:32 PM

Wednesday, March 29, 2017 3:13:32 PM

Post# of 294
MYL -3% on CRL for generic Advair:

http://finance.yahoo.com/news/mylan-comments-generic-advair-diskus-171600156.html

In conjunction with Mylan's GDUFA goal date, the company received a complete response letter from FDA regarding its ANDA for generic Advair Diskus®. Mylan is in the process of reviewing this response and will provide an update on its application as soon as practicable once it has completed its review and discussed the FDA's feedback with the agency.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTRS News